STAT‐1: a novel regulator of apoptosis

Summary.  Extracellular signalling molecules binding to their specific receptors are able to modulate gene expression, leading to changes in development, cell growth and homeostasis. The signal transducers and activators of transcription (STAT) protein family members are among the best studied of the latent cytoplasmic signal‐dependent transcription factors. The STAT factors are activated via phosphorylation on the C‐terminal domain following cytokine signalling or by various stress‐induced stimuli. Recently, STAT‐1 has been implicated in modulating pro‐ and anti‐apoptotic genes following several stress‐induced responses. These effects are dependent on STAT‐1 phosphorylation on serine‐727 and require the C‐terminal transactivation domain of STAT‐1 to enhance its pro‐apoptotic effect or inhibit its anti‐apoptotic effects. The STAT‐1 C‐terminal domain has been demonstrated to be important for protein–protein interaction with other transcriptional activators. The reports that STAT‐1‐deficient mice develop spontaneous and chemically induced tumours more rapidly compared to wild‐type mice and that STAT‐1‐deficient cells are more resistant to agents that induce apoptosis strongly support the argument that STAT‐1 acts as a tumour suppressor.

[1]  R. Knight,et al.  Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis* , 2000, The Journal of Biological Chemistry.

[2]  D. Latchman,et al.  The C‐terminal activation domain of the STAT‐1 transcription enhances ischemia/reperfusion‐induced apoptosis in cardiac myocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  R. Jove,et al.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. , 1998, Journal of biomedical science.

[4]  F. Lupinetti,et al.  Hypothermia Preserves Function and Signaling for Mitochondrial Biogenesis during Subsequent Ischemia Preparation of Isolated Heart , 2022 .

[5]  J. Ihle.  The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.

[6]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[7]  Aseem Kumar,et al.  Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .

[8]  A. Chong,et al.  IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. , 1998, Cancer research.

[9]  A. Porras,et al.  p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Suh,et al.  Protective effects of the green tea polyphenol (−)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils , 2000, Neuroscience Letters.

[11]  A. Stephanou.  Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. , 2003, European cytokine network.

[12]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[13]  D. Frank,et al.  The role of STATs in apoptosis. , 2002, Current molecular medicine.

[14]  G. Sutherland,et al.  Electron Microscopic Evidence against Apoptosis as the Mechanism of Neuronal Death in Global Ischemia , 1999, The Journal of Neuroscience.

[15]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[16]  Xin Lu,et al.  ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.

[17]  T. Nagata,et al.  (−)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant , 2002, Brain Research.

[18]  K. Yamashita,et al.  EFFECTS OF (‐)‐EPIGALLOCATECHIN‐3‐O‐GALLATE (GREEN TEA TANNIN) ON THE LIFE SPAN OF STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS , 1995, Clinical and experimental pharmacology & physiology. Supplement.

[19]  S. Goodbourn,et al.  STAT1 Is Inactivated by a Caspase* , 1998, The Journal of Biological Chemistry.

[20]  B. Frei,et al.  Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.

[21]  D. Latchman,et al.  The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis , 2002, Cell Death and Differentiation.

[22]  A Sasaki,et al.  Negative regulation of cytokine signaling pathways. , 2000, Annual review of immunology.

[23]  C. Jefford,et al.  Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. , 2001, Molecular cell.

[24]  R. Schreiber,et al.  Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .

[25]  D. Isenberg,et al.  Signal Transducer and Activator of Transcription-1 and Heat Shock Factor-1 Interact and Activate the Transcription of the Hsp-70 and Hsp-90β Gene Promoters* , 1999, The Journal of Biological Chemistry.

[26]  M. Lythgoe,et al.  MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia , 2004, Neuroscience.

[27]  D. Hilton,et al.  Negative regulation of cytokine signaling , 2001, Journal of leukocyte biology.

[28]  H. Yasuda,et al.  Involvement of PIAS1 in the sumoylation of tumor suppressor p53. , 2001, Molecular cell.

[29]  Lloyd J. Old,et al.  The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .

[30]  E. L. Koenig.  Interferon: a review. , 1970, Delaware medical journal.

[31]  D. Latchman,et al.  Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters , 2000, Cell Death and Differentiation.

[32]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[33]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Hilton,et al.  SOCS: physiological suppressors of cytokine signaling. , 2000, Journal of cell science.

[35]  R. Knight,et al.  Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701* , 2001, The Journal of Biological Chemistry.

[36]  S. Mariotto,et al.  Anti-interferon gamma action of epigallocatechin-3-gallate mediated by specific inhibition of STAT1 activation. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  R. Knight,et al.  STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[38]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Latchman,et al.  The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21CIP1/Waf1 , 2002, Oncogene.

[40]  S. Williams,et al.  Moderate hypothermia ameliorates liver energy failure after intestinal ischaemia-reperfusion in anaesthetised rats. , 2001, Journal of pediatric surgery.

[41]  J. J. Zhang,et al.  Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.